Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Jul;41(7):1702-1703.
doi: 10.1111/liv.14947. Epub 2021 May 28.

Liver dysfunction of Atezolizumab + Bevacizumab -a matter of life or death

Shuntaro Obi  1   2 , Masao Omata  2   3
Affiliations
Comment

Liver dysfunction of Atezolizumab + Bevacizumab -a matter of life or death

Shuntaro Obi et al. Liver Int. 2021 Jul.
No abstract available

PubMed Disclaimer

Comment on

References

REFERENCES

    1. Rimassa L, Wörns MA. Navigating the new landscape of second-line treatment in advanced hepatocellular carcinoma. Liver Int. 2020;40:1800-1811.
    1. Wen F, Zheng H, Zhang P, Liao W, Zhou K, Li Q. A Atezolizumab and bevacizumab combination compared with sorafenib as the first-line systemic treatment for patients with unresectable hepatocellular carcinoma: A cost-effectiveness analysis in China and the United states. Liver Int. 2021;41:1097-1104.
    1. Finn RS, Qin S, Ikeda M, et al. Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma. N Engl J Med. 2020;382:1894-1905.
    1. Gordan JD, Kennedy EB, Abou-Alfa GK, et al. Systemic Therapy For Advanced Hepatocellular Carcinoma: ASCO guideline. J Clin Oncol. 2020;38:4317-4345.
    1. Freeman-Keller M, Kim Y, Cronin H, Richards A, Gibney G, Weber JS. Nivolumab in resected and unresectable metastatic melanoma: characteristics of immune-related adverse events and association with outcomes. Clin Cancer Res. 2016;22:886-894.

MeSH terms

LinkOut - more resources